What is the correct order of the five major phases of drug development?

What is the correct order of the five major phases of drug development?

• A. Discovery → Pre-clinical research → Clinical trials → Regulatory submission and approval → Post-marketing research
• B. Pre-clinical research → Discovery → Clinical trials → Post-marketing research → Regulatory submission
• C. Discovery → Clinical trials → Pre-clinical research → Regulatory submission and approval → Post-marketing research
• D. Discovery → Pre-clinical research → Regulatory submission and approval → Clinical trials → Post-marketing research

Answer: (A)

The process follows a logical progression from idea to real-world use: first scientists identify a potential drug and understand its biological target and initial activity (discovery). Next, preclinical research uses lab and animal studies to assess safety, dosing, and pharmacology before humans are involved. Only with enough supportive data do developers move into human testing, conducting clinical trials in a staged way to evaluate safety, optimal dosing, and efficacy. After solid clinical evidence is gathered, the data are submitted to regulatory authorities for review and approval to market the drug. Once approved, post-marketing research keeps monitoring safety and effectiveness in the broader patient population. This order is why the sequence starts with discovery, then preclinical research, then clinical trials, then regulatory submission and approval, and finally post-marketing research. Reordering steps would violate dependencies—for example, you need preclinical safety data before testing in humans, you need clinical data before regulatory submission, and post-marketing surveillance occurs after approval.

The process follows a logical progression from idea to real-world use: first scientists identify a potential drug and understand its biological target and initial activity (discovery). Next, preclinical research uses lab and animal studies to assess safety, dosing, and pharmacology before humans are involved. Only with enough supportive data do developers move into human testing, conducting clinical trials in a staged way to evaluate safety, optimal dosing, and efficacy. After solid clinical evidence is gathered, the data are submitted to regulatory authorities for review and approval to market the drug. Once approved, post-marketing research keeps monitoring safety and effectiveness in the broader patient population.

This order is why the sequence starts with discovery, then preclinical research, then clinical trials, then regulatory submission and approval, and finally post-marketing research. Reordering steps would violate dependencies—for example, you need preclinical safety data before testing in humans, you need clinical data before regulatory submission, and post-marketing surveillance occurs after approval.